Clinical Trial

Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During CABG Surgeries in Egyptian Patients.

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
A randomized controlled trial on adults who underwent coronary artery bypass grafting (CABG) surgery. To evaluate the effectiveness of intraoperative continuous infusion (CI) of cefazolin compared with intermittent (INT) cefazolin administration in preventing surgical site infection in the CABG population. Eligible patients will be randomized using a block design into 2 groups: intervention and control. The intervention group will use continuous infusion of cefazolin (CI), while the control group will follow the traditional presurgical prophylaxis protocol of intermittent cefazolin doses (INT).
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-06-25
Trial Details
NCT Number NCT07658378
Lead Sponsor Helwan University
Conditions Surgical Site Infection (SSI)
Enrollment 100 participants
Start Date 2026-07-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-24